Join representatives from academia, industry and regulatory agencies, to analyze the transitional process from discovery and regulatory approval to the therapeutic use of stem cell products. Experts will present specific examples of, and solutions for, issues related to the preclinical, CMC, and clinical stages of development for stem cell products